Earkart Limited

Earkart Limited

₹ 219 -5.00%
24 Oct - close price
About

Earkart Manufacture and distribute modern hearing aids and related accessories at affordable price across India. Along with our own manufactured hearing aid, we also trade in hearing aid, parts and accessories of other brands manufactured in India and abroad.(Source : 202509 Prospectus Page No: 20)

Key Points

Business Profile[1]
Earkart manufactures and distributes modern hearing aids (BTE & RIC) and accessories, trades third-party hearing aids and parts, and also supplies mobility aids (foldable walkers) and educational/therapy kits (MSIED and TLM) for children with disabilities.

  • Market Cap 302 Cr.
  • Current Price 219
  • High / Low 266 / 136
  • Stock P/E 43.9
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 45.1 %
  • ROE 41.8 %
  • Face Value 10.0

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 35.3%

Cons

  • Company has high debtors of 159 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
5.66 28.42 30.80 42.75
5.52 26.79 27.22 32.96
Operating Profit 0.14 1.63 3.58 9.79
OPM % 2.47% 5.74% 11.62% 22.90%
0.04 0.05 0.21 0.09
Interest 0.01 0.08 0.36 0.44
Depreciation 0.06 0.15 0.19 0.42
Profit before tax 0.11 1.45 3.24 9.02
Tax % 0.00% 9.66% 5.86% 23.61%
0.11 1.31 3.06 6.88
EPS in Rs 22.00 262.00 612.00 6.59
Dividend Payout % 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 96%
TTM: 39%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 297%
TTM: 125%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 35%
Last Year: 42%

Balance Sheet

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.05 0.05 0.05 10.44
Reserves 4.72 6.49 12.97 9.48
0.27 1.23 4.02 4.96
0.91 6.96 2.21 5.41
Total Liabilities 5.95 14.73 19.25 30.29
0.22 0.25 1.06 1.17
CWIP 0.00 0.00 0.00 0.00
Investments 1.46 0.10 0.19 0.83
4.27 14.38 18.00 28.29
Total Assets 5.95 14.73 19.25 30.29

Cash Flows

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
-2.83 -0.30 -1.00 0.71
-1.78 0.40 -1.29 -1.32
4.68 0.41 3.08 -0.41
Net Cash Flow 0.07 0.51 0.80 -1.01

Ratios

Figures in Rs. Crores

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 104.47 60.36 75.13 158.55
Inventory Days 138.26 100.90 113.12 95.52
Days Payable 92.17 107.33 19.28 44.04
Cash Conversion Cycle 150.56 53.93 168.97 210.03
Working Capital Days 192.17 61.90 111.40 140.19
ROCE % 23.89% 29.02% 45.13%

Shareholding Pattern

Numbers in percentages

11 Recently
Sep 2025
57.34%
5.14%
12.61%
24.90%
No. of Shareholders 530

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents